Speaker Profile

Associate Director, US Market Access, Illumina

Ashley's work at Illumina is focused on increasing US payer coverage of NGS diagnostics and screening tests, particularly in the areas of rare disease, reproductive health, and oncology. With 15 years of experience in healthcare, Ashley previously held positions in sales, marketing, and market access at leading U.S. pharmaceutical companies and clinical laboratories, such as AstraZeneca, Counsyl (now Myriad Women's Health), and Invitae. Her unique background brings an understanding of the challenges facing stakeholders in the implementation of personalized medicine. Being part of a family impacted by rare disease, Ashley has a deeply personal passion for making personalized medicine part of routine clinical care.

Sharing Insights on Payer Coverage
Payer coverage is vital for personalized medicine to become part of routine clinical care. Over the last 5 years, payer coverage of NGS testing has grown tremendously. We will take a look at where coverage stands today and where it is moving in the years to come.

 Session Abstract – PMWC 2022 Silicon Valley

Track Chair:
Ed Esplin, Invitae

Genetic testing has evolved over time and various applications have successfully made it into the clinical setting. While oncology applications are dominating, we also see a rise in genetic/genomic applications for reproductive health, CVD diagnosis, or early life understanding. Technological advancements are required to scale genetic testing applications delivery including relay of genomic information to clinicians and patients. In parallel to technological challenges, hurdles are also observed when it comes to insight/knowledge extraction, reporting of clinical findings, and scaling of genetic counseling. This track will touch upon these various aspects including successful precision medicine models through biopharma ventures for rare disease understanding and direct to consumer genetic testing.


  • The Path to Universal Newborn Sequencing and Disease Prevention
    - Robert C Green, Harvard
  • Intro to Genetic Testing Applications
    - Ed Esplin, Invitae
  • Evolving Paradigms in Genetic Testing Initiated by Consumers
    - Paldeep S. Atwal, PWN Health
  • Models of Successful Precision Medicine through Biopharma Ventures in Rare Disease
    - Daniel Anderson, Invitae
    - Karen Miga, UCSC
  • Pairing Somatic Cancer Testing with Germline Testing
    - Ed Esplin, Invitae
  • Scalable Approaches to Relaying Genomic Information to Clinicians and their Patients
    - Steven Bleyl, Genome Medical
    - Cassie Hajek, Sanford Imagenetics
  • Lessons Learned from Virtual Genetic Counseling
    - Peter Hulick , NorthShore
  • Sharing Insights On Reimbursement
    - Ashley Arthur, Illumina